Latest Gilead Sciences Stories
CRANFIELD, England, February 26, 2015 /PRNewswire/ -- Now in its fifth year, the Productive Innovation Index (PII) celebrates the top 30 pharmaceutical companies most successful
PITTSBURGH and HYDERABAD, India, Feb. 23, 2015 /PRNewswire/ -- Mylan Inc.
RnRMarketResearch.com adds "Acute Heart Failure - Pipeline Review, H1 2015" report to its store.
When used in combination with a currently-available antiviral medication, a new experimental hepatitis C drug eradicated all signs of the disease within six weeks – the highest response and shortest duration ever achieved by any two-drug combination treatment.
LONDON, February 9, 2015 /PRNewswire/ -- London's status as a leading centre for the life sciences, financial and digital industries has attracted significant new investment
RnRMarketResearch.com adds “Coronary Artery Disease (CAD) (Ischemic Heart Disease) – Pipeline Review, H1 2015” report to its store.
Receives Notice of Allowance for Composition of Matter Patent Extending Exclusivity Coverage to at least 2031 EDISON, N.J., Feb.
RnRMarketResearch.com adds "Steatohepatitis Global Clinical Trials Review, H1, 2015" to its store.
RnRMarketResearch.com adds “Pulmonary Fibrosis – Pipeline Review, H1 2015” to its store.